These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 25190348)

  • 1. MEKK2 regulates paxillin ubiquitylation and localization in MDA-MB 231 breast cancer cells.
    Ameka M; Kahle MP; Perez-Neut M; Gentile S; Mirza AA; Cuevas BD
    Biochem J; 2014 Nov; 464(1):99-108. PubMed ID: 25190348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MEKK2 regulates focal adhesion stability and motility in invasive breast cancer cells.
    Mirza AA; Kahle MP; Ameka M; Campbell EM; Cuevas BD
    Biochim Biophys Acta; 2014 May; 1843(5):945-54. PubMed ID: 24491810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction with the Paxillin LD1 Motif Relieves MEKK2 Auto-inhibition.
    Kahle MP; Cuevas BD
    J Mol Signal; 2015 Oct; 10():4. PubMed ID: 27096002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MLK3 regulates paxillin phosphorylation in chemokine-mediated breast cancer cell migration and invasion to drive metastasis.
    Chen J; Gallo KA
    Cancer Res; 2012 Aug; 72(16):4130-40. PubMed ID: 22700880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of c-Jun N-terminal kinase by MEKK-2 and mitogen-activated protein kinase kinase kinases in rheumatoid arthritis.
    Hammaker DR; Boyle DL; Chabaud-Riou M; Firestein GS
    J Immunol; 2004 Feb; 172(3):1612-8. PubMed ID: 14734742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Defining MAP3 kinases required for MDA-MB-231 cell tumor growth and metastasis.
    Cronan MR; Nakamura K; Johnson NL; Granger DA; Cuevas BD; Wang JG; Mackman N; Scott JE; Dohlman HG; Johnson GL
    Oncogene; 2012 Aug; 31(34):3889-900. PubMed ID: 22139075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MEKK2 associates with the adapter protein Lad/RIBP and regulates the MEK5-BMK1/ERK5 pathway.
    Sun W; Kesavan K; Schaefer BC; Garrington TP; Ware M; Johnson NL; Gelfand EW; Johnson GL
    J Biol Chem; 2001 Feb; 276(7):5093-100. PubMed ID: 11073940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myoferlin depletion elevates focal adhesion kinase and paxillin phosphorylation and enhances cell-matrix adhesion in breast cancer cells.
    Blackstone BN; Li R; Ackerman WE; Ghadiali SN; Powell HM; Kniss DA
    Am J Physiol Cell Physiol; 2015 Apr; 308(8):C642-9. PubMed ID: 25631868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of MEKK2-MEK5 in the regulation of TNF-alpha gene expression and MEKK2-MKK7 in the activation of c-Jun N-terminal kinase in mast cells.
    Chayama K; Papst PJ; Garrington TP; Pratt JC; Ishizuka T; Webb S; Ganiatsas S; Zon LI; Sun W; Johnson GL; Gelfand EW
    Proc Natl Acad Sci U S A; 2001 Apr; 98(8):4599-604. PubMed ID: 11274363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MEKK2 is required for T-cell receptor signals in JNK activation and interleukin-2 gene expression.
    Su B; Cheng J; Yang J; Guo Z
    J Biol Chem; 2001 May; 276(18):14784-90. PubMed ID: 11278622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MEF2C regulates c-Jun but not TNF-alpha gene expression in stimulated mast cells.
    Wei X; Sun W; Fan R; Hahn J; Joetham A; Li G; Webb S; Garrington T; Dakhama A; Lucas J; Johnson GL; Gelfand EW
    Eur J Immunol; 2003 Oct; 33(10):2903-9. PubMed ID: 14515274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MEKK2 regulates the coordinate activation of ERK5 and JNK in response to FGF-2 in fibroblasts.
    Kesavan K; Lobel-Rice K; Sun W; Lapadat R; Webb S; Johnson GL; Garrington TP
    J Cell Physiol; 2004 Apr; 199(1):140-8. PubMed ID: 14978743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ARF1 regulates adhesion of MDA-MB-231 invasive breast cancer cells through formation of focal adhesions.
    Schlienger S; Ramirez RA; Claing A
    Cell Signal; 2015 Mar; 27(3):403-15. PubMed ID: 25530216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MEKK2 gene disruption causes loss of cytokine production in response to IgE and c-Kit ligand stimulation of ES cell-derived mast cells.
    Garrington TP; Ishizuka T; Papst PJ; Chayama K; Webb S; Yujiri T; Sun W; Sather S; Russell DM; Gibson SB; Keller G; Gelfand EW; Johnson GL
    EMBO J; 2000 Oct; 19(20):5387-95. PubMed ID: 11032806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serine phosphorylation of paxillin by heregulin-beta1: role of p38 mitogen activated protein kinase.
    Vadlamudi R; Adam L; Talukder A; Mendelsohn J; Kumar R
    Oncogene; 1999 Dec; 18(51):7253-64. PubMed ID: 10602479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paxillin, a novel controller in the signaling of estrogen to FAK/N-WASP/Arp2/3 complex in breast cancer cells.
    Shortrede JE; Uzair ID; Neira FJ; Flamini MI; Sanchez AM
    Mol Cell Endocrinol; 2016 Jul; 430():56-67. PubMed ID: 27095481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MEK kinase 2 and the adaptor protein Lad regulate extracellular signal-regulated kinase 5 activation by epidermal growth factor via Src.
    Sun W; Wei X; Kesavan K; Garrington TP; Fan R; Mei J; Anderson SM; Gelfand EW; Johnson GL
    Mol Cell Biol; 2003 Apr; 23(7):2298-308. PubMed ID: 12640115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic interaction of MEK kinase 2, c-Jun N-terminal kinase (JNK) kinase 2, and JNK1 results in efficient and specific JNK1 activation.
    Cheng J; Yang J; Xia Y; Karin M; Su B
    Mol Cell Biol; 2000 Apr; 20(7):2334-42. PubMed ID: 10713157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calpain-mediated proteolysis of paxillin negatively regulates focal adhesion dynamics and cell migration.
    Cortesio CL; Boateng LR; Piazza TM; Bennin DA; Huttenlocher A
    J Biol Chem; 2011 Mar; 286(12):9998-10006. PubMed ID: 21270128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human breast cancer cell metastasis is attenuated by lysyl oxidase inhibitors through down-regulation of focal adhesion kinase and the paxillin-signaling pathway.
    Chen LC; Tu SH; Huang CS; Chen CS; Ho CT; Lin HW; Lee CH; Chang HW; Chang CH; Wu CH; Lee WS; Ho YS
    Breast Cancer Res Treat; 2012 Aug; 134(3):989-1004. PubMed ID: 22434522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.